ENST00000377993.8:n.1334-299T>G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000377993.8(CMAHP):​n.1334-299T>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.465 in 152,044 control chromosomes in the GnomAD database, including 17,585 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.46 ( 17585 hom., cov: 32)

Consequence

CMAHP
ENST00000377993.8 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.96

Publications

5 publications found
Variant links:
Genes affected
CMAHP (HGNC:2098): (cytidine monophospho-N-acetylneuraminic acid hydroxylase, pseudogene) Sialic acids are terminal components of the carbohydrate chains of glycoconjugates involved in ligand-receptor, cell-cell, and cell-pathogen interactions. The two most common forms of sialic acid found in mammalian cells are N-acetylneuraminic acid (Neu5Ac) and its hydroxylated derivative, N-glycolylneuraminic acid (Neu5Gc). Studies of sialic acid distribution show that Neu5Gc is not detectable in normal human tissues although it was an abundant sialic acid in other mammals. Neu5Gc is, in actuality, immunogenic in humans. The absense of Neu5Gc in humans is due to a deletion within the human gene CMAH encoding cytidine monophosphate-N-acetylneuraminic acid hydroxylase, an enzyme responsible for Neu5Gc biosynthesis. Sequences encoding the mouse, pig, and chimpanzee hydroxylase enzymes were obtained by cDNA cloning and found to be highly homologous. However, the homologous human cDNA differs from these cDNAs by a 92-bp deletion in the 5' region. This deletion, corresponding to exon 6 of the mouse hydroxylase gene, causes a frameshift mutation and premature termination of the polypeptide chain in human. It seems unlikely that the truncated human hydroxylase mRNA encodes for an active enzyme explaining why Neu5Gc is undetectable in normal human tissues. Human genomic DNA also shows evidence of this deletion which does not occur in the genomes of African great apes. Nonetheless, the CMAH gene maps to 6p21.32 in humans and great apes indicating that mutation of the CMAH gene occurred following human divergence from chimpanzees and bonobos. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.597 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000377993.8. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CMAHP
NR_002174.2
n.1326-299T>G
intron
N/A

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CMAHP
ENST00000377993.8
TSL:1
n.1334-299T>G
intron
N/A
CMAHP
ENST00000377989.8
TSL:2
n.1846-299T>G
intron
N/A
CMAHP
ENST00000490939.1
TSL:3
n.560-299T>G
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.465
AC:
70651
AN:
151926
Hom.:
17573
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.271
Gnomad AMI
AF:
0.576
Gnomad AMR
AF:
0.492
Gnomad ASJ
AF:
0.614
Gnomad EAS
AF:
0.562
Gnomad SAS
AF:
0.614
Gnomad FIN
AF:
0.562
Gnomad MID
AF:
0.582
Gnomad NFE
AF:
0.533
Gnomad OTH
AF:
0.496
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.465
AC:
70681
AN:
152044
Hom.:
17585
Cov.:
32
AF XY:
0.471
AC XY:
35017
AN XY:
74326
show subpopulations
African (AFR)
AF:
0.271
AC:
11230
AN:
41486
American (AMR)
AF:
0.492
AC:
7517
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.614
AC:
2131
AN:
3468
East Asian (EAS)
AF:
0.562
AC:
2907
AN:
5172
South Asian (SAS)
AF:
0.615
AC:
2969
AN:
4824
European-Finnish (FIN)
AF:
0.562
AC:
5926
AN:
10538
Middle Eastern (MID)
AF:
0.595
AC:
175
AN:
294
European-Non Finnish (NFE)
AF:
0.533
AC:
36246
AN:
67948
Other (OTH)
AF:
0.500
AC:
1056
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1844
3688
5532
7376
9220
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
656
1312
1968
2624
3280
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.492
Hom.:
2969
Bravo
AF:
0.450
Asia WGS
AF:
0.582
AC:
2024
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
0.10
DANN
Benign
0.65
PhyloP100
-2.0

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3818270; hg19: chr6-25092539; API